Search

You searched for "presentation"

668 results found

Demanding cases or nightmares in endourology? May/June 2017

1 May 2017 | | URO - Endourology & Stones
In the sixth article in this series the authors describe endourology nightmares involving ileal conduits and calculi. Case 1 A 69-year-old man who had a cystectomy and ileal conduit for muscle invasive bladder cancer, presented with an acute kidney injury...

International urology returns to Scotland

31 March 2025 | URO - Core Urology
Founded in 1907, the SIU has established itself as the premier international professional society for urologists. As global interdependence increases, so does the relevance of the Society’s mission to enable urologists in all nations to apply the highest standards of...

Botulinum toxin – from the sausage poison to urology

4 May 2023 | | URO - Functional / Reconstructive Urology, URO - Infection
Botulinum toxin is the first biological toxin to be licensed for use in treating human disease and since its first therapeutic use in the early 1980s for strabismus has become widely used in the fields of ophthalmology, cosmetic surgery, migraine...

Bladder carcinoma MRI

1 September 2018 | | URO - Urologic Oncology, URO - Uroradiology
Bladder malignancy is one of the commonest malignancies of the renal tract, accounting for approximately 6% of male malignancy and 2% of female malignancy. The incidence increases with patient age with 70% of patients being over the age of 65...

USANZ Trainee Week 2022 – a trip down under

11 July 2023 | | URO - Core Urology
The BAUS Section of Trainees (BSoT) opened applications for two senior UK urology trainees to be sponsored to attend the annual Urological Society of Australia and New Zealand (USANZ) Trainee Week, in Melbourne. The week is held in November each...

Keeping your eye on the ball: atypical presentations of testicular malignancy

4 March 2025 | | URO - Urologic Oncology
Most testicular cancers present with a painless lump on the testes, and most are confidently diagnosed on examination and ultrasound. They have an excellent prognosis, with 90% patients alive at 10 years [1]. However, advanced testicular cancer, or those with...

Quality Improvement – how to get involved?

1 November 2018 | | URO - Core Urology
The General Medical Council (GMC) requires all trainee doctors to carry out Quality Improvement (QI) as part of our annual appraisal process [1]. Exactly what QI projects are and how to get involved is less widely understood. Traditionally surgical trainees...

Clinical trials 1

1 January 2017 | URO - Basic Science Research
Clinical Trials 2 is available here. Case 1 1. What are the levels of clinical evidence based on the 2009 definitions from the ‘Oxford CEBM’? 2. What is the null hypothesis? 3. What are type 1 and type 2 errors?...

Urinary tract stones

9 March 2020 | URO - Endourology & Stones
Case 1 What does this plain X-ray of kidneys, ureters and bladder (KUB) show? What, according to the 2009 The National Institute for Health and Care Excellence (NICE) guidelines, is the most appropriate first-line treatment? What factors do the NICE...

An update on antibiotic prophylaxis in TRUS-guided prostate biopsy

1 November 2016 | | URO - Urologic Oncology, URO - Infection
Since its inception in the 1980s, transrectal ultrasound (TRUS)-guided prostate biopsy has remained the standard tool for the histological diagnosis of prostate cancer. There are several advantages to this technique which have led to the widespread use of TRUS in...

The Lister Royal College of Surgeons of England / BAUS Accredited Robotic Urological Fellowship Programme

1 September 2015 | | URO - Core Urology
Robotic fellowship training in the UK – overview Robotic surgery has increased in popularity since its introduction in 2003. Its validation in a growing number of operative procedures has increased its acceptance nationwide and its usage is becoming widespread. Initial...

Onco-fertility: a review

7 January 2020 | | URO - Andrology, URO - Urologic Oncology
Subfertility or infertility is a major problem affecting men diagnosed with testicular cancer (TC) either due to the disease itself [1], or as a result of management [2]. TC is the most prevalent cancer affecting men of reproductive age [3]....